|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,994 DKK | -0.62% |
|
-3.32% | -7.45% |
| Apr. 16 | Genmab, Johnson & Johnson Logs Higher Q1 Sales for Blood Cancer Drug | MT |
| Apr. 16 | Genmab A/S Announces DARZALEX Sales Results for the First Quarter of 2024 | CI |
The Articles of Association can be found on
Contact:
Tel: +1 609 524 0065
Email: mmp@genmab.com
(C) 2020 Electronic News Publishing, source
| 1st Jan change | Capi. | |
|---|---|---|
| -7.45% | 18.6B | |
| -3.30% | 102B | |
| +1.79% | 96.84B | |
| -0.44% | 21.48B | |
| -18.35% | 20.82B | |
| -40.31% | 16.81B | |
| -26.84% | 13.78B | |
| +0.59% | 13.4B | |
| +20.86% | 11.06B | |
| -21.69% | 8.88B |
GENMAB A/S 
